Obesity is associated with insulin resistance, leading to increased binding of insulin-like growth factor1 (IGF-1) to its receptor, acting like a growth factor and therefore promoting oncogenesis, tumor progression, and metastasis (31, 34). This evidence concerns the gene IGF1 and obesity disorder.